EU-PRESSURE_EQUIPMENT-ART_13_1_a
EU-PRESSURE_EQUIPMENT-ART_13_1_a
Pressure Equipment Directive - Group 1 Fluids Hazardous Substances
EU. Group 1 Fluids per Article 13(1)(a), Directive 2014/68/EU on Pressure Equipment, 27 June 2014
This list contains a non-exhaustive inventory of hazardous substances based on Article 13(1)(a) of Directive 2014/68/EU, defining Group 1 fluids for purposes of classifying pressure equipment in accordance with the Directive. The list is derived from a subset of the substances with harmonised classifications, as listed on Table 3 of Annex VI to the CLP Regulation 1272/2008/EC.
Last updated 16 maggio 2024. Database contains 1192 unique substances/entries.
Filter the list
|
-
|
-
|
005-017-00-7 |
Ox. Sol. 2 |
containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm |
|||
|
-
|
-
|
005-017-01-4 |
Ox. Sol. 2; Acute Tox. 3 (Inhalation) |
containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm |
|||
|
231-556-4
|
7632-04-4
|
005-017-00-7 |
Ox. Sol. 2 |
containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm |
|||
|
231-556-4
|
7632-04-4
|
005-017-01-4 |
Ox. Sol. 2; Acute Tox. 3 (Inhalation) |
containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm |
|||
|
219-007-7
|
2312-76-7
|
609-021-00-5 |
Acute Tox. 3 (Inhalation) |
||||
|
233-267-9
|
10102-18-8
|
034-003-00-3 |
Acute Tox. 2 (Oral); Acute Tox. 3 (Inhalation) |
||||
|
205-025-2
|
131-52-2
|
604-003-00-3 |
Acute Tox. 2 (Inhalation) |
||||
|
234-239-9
|
11005-63-3
|
614-026-00-0 |
Acute Tox. 3 (Inhalation) |
||||
|
269-710-8
|
68310-42-9
|
614-007-00-7 |
Acute Tox. 2 (Oral); Acute Tox. 2 (Inhalation) |
||||
|
269-439-5
|
68239-26-9
|
614-007-00-7 |
Acute Tox. 2 (Oral); Acute Tox. 2 (Inhalation) |
||||
|
200-319-7
|
57-24-9
|
614-003-00-5 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
202-851-5
|
100-42-5
|
601-026-00-0 |
Flam. Liq. 3 |
||||
|
-
|
-
|
||||||
|
222-995-2
|
3689-24-5
|
015-027-00-3 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
231-195-2
|
7446-09-5
|
016-011-00-9 |
STOT SE 1; Acute Tox. 3 (Inhalation) |
||||
|
220-281-5
|
2699-79-8
|
009-015-00-7 |
Acute Tox. 3 (Inhalation) |
||||
|
201-782-8
|
87-90-1
|
613-031-00-5 |
Ox. Sol. 2 |
||||
|
616-699-6
|
79538-32-2
|
607-723-00-6 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal); Acute Tox. 1 (Inhalation); Acute Tox. 2 (Inhalation) |
||||
|
203-495-3
|
107-49-3
|
015-025-00-2 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
235-963-8
|
13071-79-9
|
015-139-00-2 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
208-760-7
|
540-88-5
|
607-026-00-7 |
Flam. Liq. 2 |
||||
|
216-768-7
|
1663-39-4
|
607-245-00-8 |
Flam. Liq. 2 |
||||
|
212-105-0
|
762-75-4
|
607-017-00-8 |
Flam. Liq. 2 |
||||
|
216-653-1
|
1634-04-4
|
603-181-00-X |
Flam. Liq. 2 |
||||
|
208-757-0
|
540-80-7
|
007-019-00-3 |
Flam. Liq. 2 |
||||
|
606-566-0
|
20487-40-5
|
607-697-00-6 |
Flam. Liq. 2 |
||||
|
222-389-8
|
3457-61-2
|
617-007-00-5 |
Org. Perox. E |
||||
|
TERTIARYBUTYLARSINE; TERTIÄRBUTYLARSIN
|
423-320-6
|
4262-43-5
|
033-007-00-2 |
Pyr. Liq. 1; Acute Tox. 2 (Inhalation) |
|||
|
236-669-2
|
13463-39-3
|
028-001-00-1 |
Flam. Liq. 2; Acute Tox. 2 (Inhalation) |
||||
|
201-083-8
|
78-10-4
|
014-005-00-0 |
Flam. Liq. 3 |
||||
|
203-726-8
|
109-99-9
|
603-025-00-0 |
Flam. Liq. 2 |
||||
|
203-728-9
|
110-01-0
|
613-087-00-0 |
Flam. Liq. 2 |
||||
|
SUBSTANCE TP-415; SUBSTANZ TP-415; TP-415
|
404-760-8
|
117342-25-3
|
042-002-00-4 |
Acute Tox. 3 (Inhalation) |
|||
|
tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)
TP-302
|
404-860-1
|
116810-46-9
|
042-003-00-X |
Flam. Sol. 1 |
|||
|
215-245-0
|
1314-85-8
|
015-012-00-1 |
Flam. Sol. 2; Water-react. 1 |
||||
|
231-138-1
|
7440-28-0
|
081-001-00-3 |
Acute Tox. 2 (Oral); Acute Tox. 2 (Inhalation) |
||||
|
show/hide
Leach residues, zinc refining flue dust, cadmium-thallium ppt.
Sponge produced by leaching and precipitating cadmium and thallium fumes and flue dusts from lead/zinc smelting operations.
EC / List no:
296-097-4
| CAS no:
92257-11-9
Waste solids, cadmium-electrolysis, thallium-rich
Residue obtained in the electrolysis of cadmium, composed primarily of thallium chromate. Other non-ferrous metals or metal compounds may also be present.
EC / List no:
285-572-1
| CAS no:
85117-20-0
Slimes and Sludges, thallium
Product of adding a sulfidizer to a thallium-rich solution during lead refining. Consists primarily of thallium and cadmium sulfides.
EC / List no:
273-835-3
| CAS no:
69029-95-4
|
-
|
-
|
081-002-00-9 |
Acute Tox. 2 (Oral); Acute Tox. 2 (Inhalation) |
|||
|
222-571-7
|
3535-84-0
|
615-031-00-0 |
Acute Tox. 2 (Oral); Acute Tox. 2 (Inhalation) |
||||
|
207-341-6
|
463-71-8
|
607-201-00-8 |
Acute Tox. 3 (Inhalation) |
||||
|
254-346-4
|
39196-18-4
|
006-064-00-6 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
200-677-4
|
68-11-1
|
607-090-00-6 |
Acute Tox. 3 (Inhalation) |
||||
|
206-049-6
|
297-97-2
|
015-112-00-5 |
Acute Tox. 1 (Oral); Acute Tox. 2 (Oral); Acute Tox. 1 (Dermal); Acute Tox. 2 (Dermal) |
||||
|
203-625-9
|
108-88-3
|
601-021-00-3 |
Flam. Liq. 2 |
||||
|
216-407-3
|
1576-35-8
|
607-759-00-2 |
Self-react. D |
||||
|
208-741-3
|
540-25-0
|
612-160-00-4 |
Acute Tox. 3 (Inhalation) |
||||
|
208-740-8
|
540-23-8
|
612-160-00-4 |
Acute Tox. 3 (Inhalation) |
||||
|
211-986-9
|
731-27-1
|
613-116-00-7 |
Acute Tox. 2 (Inhalation) |
containing ≥0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm |
|||
|
229-977-3
|
6876-12-6
|
601-029-00-7 |
Flam. Liq. 3 |
||||
|
205-860-2
|
156-60-5
|
602-026-00-3 |
Flam. Liq. 2 |
||||
|
443-150-6
|
101226-85-1
|
607-665-00-1 |
Flam. Liq. 3 |
||||